ARMISTICE CAPITAL, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Aptose Biosciences Inc. Common Shares, no par value (APTO)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Aptose Biosciences Inc. Common Shares, no par value
Symbol: APTO
Shares outstanding: 20,546,433 shares
Disclosed Ownership: 1,025,267 shares
Ownership: 5%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 16:57:42 UTC
Date of event: 31 Dec 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5%	1,025,267	0	1,025,267	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5%	1,025,267	0	1,025,267	/s/ Steven Boyd	Steven Boyd